MRNA

Moderna, Inc.

NasdaqGSUSDEQUITY DELAYED

145.80

▲ 12.48 (9.36%)

MARKET · —

Price

Open

134.32

Prev close

133.32

Day high

159.47

Day low

132.43

Volume

86.74M

Market cap

—

P/E (TTM)

—

52W range

22.28 – 176.66

Trailing performance

Price return · vs SPY

Returnvs SPY

+129.20% +130.6%

+154.52% +150.8%

+207.09% +204.0%

+191.02% +180.0%

YTD

+392.13% +379.8%

+439.72% +419.7%

+46.71% -27.5%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

89.13

+63.59% from price

SMA 20

72.57

+99.99% from price

SMA 50

67.60

+114.68% from price

SMA 100

58.58

+148.87% from price

SMA 200

48.73

+197.84% from price

EMA 12

95.98

+51.91% from price

EMA 26

79.10

+84.33% from price

EMA 50

69.84

+108.77% from price

RSI (14)

71.6

Overbought

MACD (12,26,9)

16.88

Hist 10.33

ATR (14)

16.11

11.10% of price

Realised vol 30D

308.7%

Annualised

Bollinger upper

140.09

20, 2σ

Bollinger lower

5.04

20, 2σ

50 / 200 cross

Golden

67.60 vs 48.73

Trend bias

Above 200

+197.84%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.89

More volatile than market

Correlation to SPY

0.13

Largely independent

Realised vol 30D

308.7%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-34.2%

Peak to trough

Max drawdown 5Y

-95.1%

Peak to trough

ATR 14

16.11

11.10% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 145.80

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

MRNA · links out to the publisher

Investors Thought Moderna Was Left for Dead. Then Came a Cancer Breakthrough. The Wall Street Journal · 4h ago Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical StockStory · 7h ago ARCT Surges Over 60% Toward Best Week In Year As Moderna Cancer Win Lifts Sector — Retail Says Arcturus Getting ‘Harder To Dismiss’ Stocktwits · 15h ago How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink The Wall Street Journal · 15h ago 3 American Stocks Showing the Same Setup That Sent Moderna Up 177% BeInCrypto · 17h ago Moderna, Merck Cancer Vax Gives Hope Bloomberg · 17h ago SLS Stock Clocks Three Straight Weeks Of Gains On Cancer Vaccine Spillover, REGAL Trial Data Anticipation Stocktwits · 18h ago Stocks to Watch Recap: Strategy, Ross Stores, BJ’s Wholesale Club The Wall Street Journal · 18h ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.